BackgroundCheck.run
Search For

Abu S Alam, 791471 Littlefield Ct, Green Oaks, IL 60045

Known as:
Abu Dr Alam Abu L Alam Abu S Norvilitis Abu S Alan Abu Salam
Related to:
Elizabeth K Norvilitis

Abu Alam Phones & Addresses

1471 Littlefield Ct, Lake Forest, IL 60045    847-2952757    847-6049228   

Libertyville, IL   

Brooklyn, NY   

Elmhurst, IL   

1471 Littlefield Ct, Lake Forest, IL 60045    312-4122429   

Work

Company: Abu S Alam MD PA Address: 779 Springfield Ave, Summit, NJ 07901 Phones: 908-2735907 (Phone)

Education

School / High School: Dhaka Medical College, Dhaka University 1972

Languages

English • Bengali

Awards

Healthgrades Honor Roll

Ranks

Certificate: Obstetrics & Gynecology, 2009
Get Report
Control this profile

Mentions for Abu S Alam

Career records & work history

Medicine Doctors

Abu Alam Photo 1

Dr. Abu S Alam, Summit NJ - MD (Doctor of Medicine)

Specialties:
Obstetrics & Gynecology
Address:
Abu S Alam MD PA
779 Springfield Ave, Summit, NJ 07901
908-2735907 (Phone)
Certifications:
Obstetrics & Gynecology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Bengali
Hospitals:
Abu S Alam MD PA
779 Springfield Ave, Summit, NJ 07901
Overlook Medical Center
99 Beauvoir Avenue, Summit, NJ 07901
Education:
Medical School
Dhaka Medical College, Dhaka University
Graduated: 1972
Medical School
Medical Center Of Louisiana
Graduated: 1977
Medical School
Saint Vincent's Hospital-Midtown
Graduated: 1980

Abu S. Alam

Specialties:
Obstetrics & Gynecology
Work:
Abu S Alam MD PA
779 Springfield Ave, Summit, NJ 07901
908-2735907 (phone) 908-2772421 (fax)
Education:
Medical School
Dhaka Med Coll, Dhaka Univ, Bangladesh
Graduated: 1972
Procedures:
Cesarean Section (C-Section), D & C Dilation and Curettage, Delivery After Previous Caesarean Section, Hysterectomy, Myomectomy, Oophorectomy, Ovarian Surgery, Skin Tags Removal, Tubal Surgery, Vaginal Delivery, Vaginal Repair
Conditions:
Endometriosis, Menopausal and Postmenopausal Disorders, Uterine Leiomyoma, Abnormal Vaginal Bleeding, Breast Disorders, Candidiasis of Vulva and Vagina, Complicating Pregnancy or Childbirth, Conditions of Pregnancy and Delivery, Ectopic Pregnancy, Female Infertility, Genital HPV, Hemorrhoids, Herpes Genitalis, Hypertension (HTN), Ovarian Dysfunction, Polycystic Ovarian Syndrome (PCOS), Spontaneous Abortion, Uncomplicated or Low Risk Pregnancy and Delivery
Languages:
English, Polish, Russian
Description:
Dr. Alam graduated from the Dhaka Med Coll, Dhaka Univ, Bangladesh in 1972. He works in Summit, NJ and specializes in Obstetrics & Gynecology. Dr. Alam is affiliated with Overlook Medical Center.
Abu Alam Photo 2

Abu Sajjadul Alam, Summit NJ

Specialties:
Obstetrics & Gynecology
Gynecology
Work:
Russell Hoffman
779 Springfield Ave, Summit, NJ 07901
Education:
Dhaka Medical College (1972)
Abu Alam Photo 3

Abu S Alam, Summit NJ

Specialties:
OB-GYN
Address:
779 Springfield Ave, Summit, NJ 07901
Education:
Dhaka Medical College - Doctor of Medicine
Board certifications:
American Board of Obstetrics and Gynecology Certification in Obstetrics & Gynecology

Abu Alam resumes & CV records

Resumes

Abu Alam Photo 42

President

Location:
Chicago, IL
Industry:
Pharmaceuticals
Work:
Newgen Biopharma Corporation Jun 2010 - Sep 2014
Senior Vice President R and D, Chief Technical Officer Pinnacle Biologics, Inc. Oct 2010 - Jul 2011
Consultant Part Time Pediatrx Jan 2010 - Jun 2010
Consultant Cytochroma Inc. Jan 2010 - Mar 2010
Consultant Ac Pharma Jan 2010 - Mar 2010
President Akorn, Inc Jul 1997 - Jul 2009
Senior Vice President New Business Development Akorn, Inc Jan 1997 - Jul 2009
Senior Vice President Akorn, Inc Jan 1997 - Jan 2000
Vice President of Research and Development and Regulatory Affairs Ej Financial Enterprises Jan 1991 - Jan 1996
Consultant Lyphomed Inc./Division of Fujisawa Jun 1984 - Feb 1990
Vice President R and D Lyphomed A Division of Fujisawa Usa Jan 1984 - Jan 1990
Vice President, Research and Development American Critical Care Division of American Hospital Supply Corporation Jan 1981 - Jan 1983
Section Head, Product Development Adria Laboratories Jan 1978 - Jan 1980
Manager, Pharmaceutical Research and Development Rohm and Haas Jan 1975 - Jan 1977
Project Scientist Rohm and Haas Jan 1971 - Jan 1974
Scientist
Education:
University of Iowa 1969 - 1971
Doctorates, Doctor of Philosophy, Pharmacy University of Iowa 1967 - 1969
Master of Science, Masters, Pharmacy Philadelphia College of Pharmacy & Science 1963 - 1967
Bachelors, Bachelor of Science, Pharmacy
Skills:
Pharmaceutical Industry, Fda, Biotechnology, Technology Transfer, Drug Development, Regulatory Affairs, Clinical Development, Validation, Gmp, Pharmaceutics, Product Launch, Lifesciences, R&D, Oncology, Commercialization, Formulation, Strategy, Life Sciences, Clinical Research, Cro, Chemistry, Manufacturing, Vaccines, Glp, Due Diligence, Mergers and Acquisitions
Abu Alam Photo 43

Abu Alam

Abu Alam Photo 44

Director, Dept Of Accounts And Hr At Tempo Networks

Location:
Greater New York City Area
Industry:
Music
Abu Alam Photo 45

Abu Alam - Brooklyn, NY

Work:
Super Builders & Properties Ltd - Dhaka May 2010 to May 2011
Marketing and Sales Agent Oriental Media and Communication - Dhaka Oct 2009 to Apr 2010
Client Service Representative
Education:
International Islamic University Chittagong - Dhaka 2010
Master of Business Administration in Human Resource Management National University of Bangladesh - Dhaka 2005
Masters in Business Administration

Publications & IP owners

Us Patents

Methods For Diagnosing And Treating Conditions Associated With Abnormal Vasculature Using Fluorescent Dye Angiography And Dye-Enhanced Photocoagulation

US Patent:
6351663, Feb 26, 2002
Filed:
Sep 10, 1999
Appl. No.:
09/393456
Inventors:
Robert W. Flower - Hunt Valley MD
Abu Alam - Lake Forest IL
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61B 600
US Classification:
600476, 600431, 2504591
Abstract:
Methods concerning medical uses for fluorescent dyes, e. g. , Indocyanine green (ICG), fluorescein, rose bengal, for diagnosis and treatment. Methods for enhancing the clarity of fluorescent dye angiograms using relatively high dye concentrations, methods for determining the direction of blood flow within a blood vessel using fluorescent dye angiograms, and methods of identifying blood vessels that feed a lesion, such as a CNV or tumor. Methods of reducing the flow of blood into lesions incorporating dye-enhanced photocoagulation are also provided.

Methods For Treating Conditions And Illnesses Associated With Abnormal Vasculature

US Patent:
6443976, Sep 3, 2002
Filed:
Nov 30, 1999
Appl. No.:
09/452117
Inventors:
Robert W. Flower - Hunt Valley MD
Abu Alam - Lake Forest IL
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61N 3300
US Classification:
607 88, 607 89, 606 2, 606 4, 600101, 600108, 604 20, 604 21, 604508
Abstract:
Use of radiation-absorbing dyes (e. g. , indocyanine green (ICG), fluorescein, rose bengal) and photodynamic dyes (e. g. , hematoporphyrins, aminolevulinic acids, porphyrins, merocyanines, porphycenes, porfimer sodium, verteporfin, Photofrin II, PH-10, chlorins, zinc phthalocyanine, purpurins, pheophorbides, monoclonal antibody-dye conjugates of any of the foregoing dyes) for the treatment of conditions associated with abnormal vasculature, including, generally, lesions, and, more specifically, tumors (cancerous and benign) and choroidal neovascularization (CNV) associated with age-related macular degeneration (ARMD).

Indocyanine Green (Icg) Compositions And Related Methods Of Use

US Patent:
6944493, Sep 13, 2005
Filed:
Dec 27, 2001
Appl. No.:
10/034432
Inventors:
Abu Alam - Lake Forest IL, US
Ashok J. Chavan - Bloomington IL, US
Robert W. Flower - Hunt Valley MD, US
Assignee:
Akora, Inc. - Buffalo Grove IL
International Classification:
A61B006/00
US Classification:
600431, 600473, 424 96, 607 89
Abstract:
Aqueous indocyanine green (ICG) composition exhibiting enhanced stability, as well as enhanced ICG concentration, as compared to presently available ICG products. The composition comprises an aqueous ICG composition comprising ICG at a concentration of at least about 10 mg/ml and an aqueous diluent, wherein the composition is stable for at least 24 hours. Diagnostic and therapeutic methods for using these aqueous compositions are also contemplated, e. g. , angiography, dye-enhanced photocoagulation, photodynamic therapy, for a variety of conditions, including Age-Related Macular Degeneration (ARMD), lesions and tumors.

Methods Of Using Indocyanine Green (Icg) Dye

US Patent:
2004015, Aug 12, 2004
Filed:
Feb 12, 2003
Appl. No.:
10/365028
Inventors:
Abu Alam - Lake Forest IL, US
Ashok Chavan - Bloomington IL, US
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61K049/00
US Classification:
424/009600
Abstract:
Methods of using indocyanine green (ICG) dye for obtaining angiographic images of tissue in a patient, determining cardiac output or hepatic function and liver blood flow, and diagnosing and treating a lesion. In each method, an aqueous ICG composition is administered to the patient more than 10 hours after the ICG has been reconstituted to form the aqueous ICG composition, and up to a maximum time limit as determined using HPLC analysis of ICG.

Triamcinolone Formulations And Methods For Their Preparation And Use

US Patent:
2004018, Sep 23, 2004
Filed:
Mar 21, 2003
Appl. No.:
10/394821
Inventors:
Abu Alam - Lake Forest IL, US
Hari Menon - Bellemead NJ, US
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61K031/58
US Classification:
514/174000
Abstract:
Sterile compositions comprising triamcinolone compounds (desirably, triamcinolone acetonide), systems for providing such compositions, and methods for the preparation and use of such compositions. Exemplary of the inventive compositions is a sterile aqueous composition comprising triamcinolone acetonide, wherein the sterile aqueous composition has a pH of between about 5 and 7.5 and contains no more than 1 wt. % excipients other than tonicity-adjusting agents and pH-adjusting agents.

Nutritional Supplement For The Treatment And Prevention Of Macular Degeneration

US Patent:
2005024, Nov 10, 2005
Filed:
May 4, 2004
Appl. No.:
10/838467
Inventors:
Abu Alam - Lake Forest IL, US
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61K033/32
A61K035/78
A61K031/12
A61K031/355
A61K031/375
US Classification:
424638000, 424643000, 514474000, 514458000, 514690000, 514725000
Abstract:
The invention provides a nutritional supplement in the form of one or more capsules comprising Vitamin A, Vitamin C, Vitamin E, and at least one carotenoid. The invention also provides a nutritional supplement in the form of one or more capsules comprising Vitamin A, Vitamin C, Vitamin E, zinc, copper, and at least one carotenoid. The invention further provides a method for the treatment and/or prevention of macular degeneration comprising the step of orally administering to a patient the nutritional supplement of the invention.

Aqueous Gel Formulation And Method For Inducing Topical Anesthesia

US Patent:
2008002, Jan 24, 2008
Filed:
May 7, 2007
Appl. No.:
11/745207
Inventors:
Abu Alam - Lake Forest IL, US
Elias Reichel - Weston MA, US
Brandon Busbee - Nashville TN, US
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61K 9/16
US Classification:
424486
Abstract:
Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.

Aqueous Gel Formulation And Method For Inducing Topical Anesthesia

US Patent:
2008002, Jan 24, 2008
Filed:
Jul 24, 2006
Appl. No.:
11/491611
Inventors:
Abu Alam - Lake Forest IL, US
Elias Reichel - Weston MA, US
Brandon Busbee - Nashville TN, US
Assignee:
Akorn, Inc. - Buffalo Grove IL
International Classification:
A61K 31/27
A61K 31/16
US Classification:
514331, 514485, 514626
Abstract:
Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.

Possible Relatives

Dewan A Alam  Elias P Alam  Faiza Alam  Fakhri Alam  Farah N Alam  Farhana Alam  Farida Alam  Abu T Rahman  Abu M Abdullah  Abu N Chowdhury 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.